These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31449345)

  • 1. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
    Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
    J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.
    Liu L; Qiu M; Tan G; Liang Z; Qin Y; Chen L; Chen H; Liu J
    J Transl Med; 2014 Nov; 12():305. PubMed ID: 25367080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
    Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
    Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway].
    Li X; Han X; Yang J; Sun J; Wei P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1360-1364. PubMed ID: 29169421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
    Cui X; Shen D; Kong C; Zhang Z; Zeng Y; Lin X; Liu X
    Sci Rep; 2017 Jan; 7():40723. PubMed ID: 28139689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3.
    Zhang Y; Zhang Z; Li Z; Gong D; Zhan B; Man X; Kong C
    Oncol Rep; 2016 Sep; 36(3):1293-300. PubMed ID: 27430325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.
    He HC; Ling XH; Zhu JG; Fu X; Han ZD; Liang YX; Deng YH; Lin ZY; Chen G; Chen YF; Mo RJ; Zhong WD
    Mol Biol Rep; 2013 May; 40(5):3799-805. PubMed ID: 23283744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer.
    Huang W; Li Y; Zhang C; Zha H; Zhou X; Fu B; Guo J; Wang G
    J Cell Mol Med; 2020 Dec; 24(23):13949-13960. PubMed ID: 33094561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-194-5p inhibits cell migration and invasion in bladder cancer by targeting E2F3.
    Wang Y; Sun G; Wang C; Guo W; Tang Q; Wang M
    J BUON; 2018; 23(5):1492-1499. PubMed ID: 30570877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma.
    He Z; Yi J; Liu X; Chen J; Han S; Jin L; Chen L; Song H
    Mol Cancer; 2016 Jun; 15(1):51. PubMed ID: 27358073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
    Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X
    J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
    Zhou X; Ji G; Ke X; Gu H; Jin W; Zhang G
    Dig Dis Sci; 2015 Nov; 60(11):3271-82. PubMed ID: 26233544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
    Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T
    Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-binding protein QKI-5 inhibits the proliferation of clear cell renal cell carcinoma via post-transcriptional stabilization of RASA1 mRNA.
    Zhang RL; Yang JP; Peng LX; Zheng LS; Xie P; Wang MY; Cao Y; Zhang ZL; Zhou FJ; Qian CN; Bao YX
    Cell Cycle; 2016 Nov; 15(22):3094-3104. PubMed ID: 27767378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.
    Hurst CD; Tomlinson DC; Williams SV; Platt FM; Knowles MA
    Oncogene; 2008 Apr; 27(19):2716-27. PubMed ID: 18037967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
    Tan ST; Liu SY; Wu B
    Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-429 inhibits neuroblastoma cell proliferation, migration and invasion via the NF-κB pathway.
    Zhou X; Lu H; Li F; Hao X; Han L; Dong Q; Chen X
    Cell Mol Biol Lett; 2020; 25():5. PubMed ID: 32082390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
    Wu X; Kong C; Wu Y
    Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.
    Eiring AM; Neviani P; Santhanam R; Oaks JJ; Chang JS; Notari M; Willis W; Gambacorti-Passerini C; Volinia S; Marcucci G; Caligiuri MA; Leone GW; Perrotti D
    Blood; 2008 Jan; 111(2):816-28. PubMed ID: 17925491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.